Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

A Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Phenobarbital and Ketamine Adjunctive Therapies in the Treatment of Alcohol Withdrawal Syndrome

To see complete record on, please visit this link

Id: NCT03788889

Organisation Name: Santa Barbara Cottage Hospital

Overal Status: Withdrawn

Start Date: April 12, 2019

Last Update: September 19, 2019

Lead Sponsor: Santa Barbara Cottage Hospital

Brief Summary: The goal of this study will aim to determine if adding phenobarbital or ketamine to a symptom-triggered benzodiazepine regimen decreases the rate of intensive care unit admissions during the treatment of alcohol withdrawal syndrome when compared to symptom-triggered benzodiazepine therapy alone.

  • Alcohol Withdrawal Syndrome

Total execution time in seconds: 0.52448201179504